Delivery Order SPE2DB22D2006-SPE2DB25FV8BY

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,049.52 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of M-M-R II vaccine vials and does not have a set-aside designation. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of M-M-R II vaccine vials to the Department of Defense (DoD) and other government agencies. The $1,024.78 Firm Fixed Price Delivery Order contract has a completion date of May 30, 2024 and was awarded on May 29, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a major procurer of medical supplies for the military. Amerisourcebergen holds a single-award Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor. The $1,537.14 delivery order is for the supply of M-M-R II vaccine vials, with a contract performance period ending on April 17, 2024. The contract is a firm fixed-price agreement and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $3,972.34 for the supply of M-M-R II vaccine vials. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 9, 2025. The contract is a Firm Fixed Price arrangement, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp (DUNS: TGxsdkVQRGhOYUpNR001SFhYRERNdz09) is a $2,168.76 firm fixed price delivery order from the Defense Logistics Agency (DLA) for the supply of M-M-R II vaccine vials. The contract has an ultimate completion date of November 15, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II vaccine vials. The contract, valued at $54,219.00, is a firm fixed-price delivery order that runs through December 13, 2024. There is no set-aside designation indicated for this award. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,424.20 firm fixed-price delivery order is for the supply of M-M-R II vaccine vials, with a completion date of November 15, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,537.17 delivery order is for the supply of M-M-R II vaccine vials, a critical medical product. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order (DO) valued at $58,442.37 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the delivery of M-M-R II Vaccine Vials and has an ultimate completion date of September 13, 2022. The contract is a Firm Fixed Price (FFP) arrangement and does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $1,087.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC enables the government to efficiently procure a comprehensive range of pharmaceutical products and medical...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV8BY
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $27,694.50 for the supply of M-M-R II vaccine vials. The contract is issued by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense, and does not have a set-aside designation.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current delivery order is one of many that fall under this broader contract mechanism. Amerisourcebergen has also been awarded a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/5/25, 9:50 AM